Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases
2019 ◽
Vol 71
◽
pp. 404-410
◽
Keyword(s):
2013 ◽
Vol 54
(2)
◽
pp. 206-214
◽
2018 ◽
Vol 104
(3)
◽
pp. 564-574
◽
2019 ◽
Vol 93
(4)
◽
pp. 386-392
◽